A Prospective Randomized Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus-Eluting Stent in the Treatment of Subjects With Up to 2 De Novo Coronary Artery Lesions-BIOFLOW IV: 4-Year Clinical Results

dc.conference.dateSEP 25-29, 2019
dc.conference.title31st Annual Symposium on Transcatheter Cardiovascular Therapeutics (TCT)
dc.contributor.authorSlagboom, Ton
dc.contributor.authorToelg, Ralph
dc.contributor.authorWitzenbichler, Bernhard
dc.contributor.authorHaude, Michael
dc.contributor.authorJose Ruiz-Salmeron, Rafael
dc.contributor.authorWitkowski, Adam
dc.contributor.authorWaksman, Ron
dc.contributor.authorSaito, Shigeru
dc.contributor.authoraffiliation[Slagboom, Ton] OLVG, Amsterdam, Netherlands
dc.contributor.authoraffiliation[Toelg, Ralph] Segeberger Kliniken, Herzzentrum, Bad Segeberg, Germany
dc.contributor.authoraffiliation[Witzenbichler, Bernhard] Helios Amper Klinikum, Dachau, Germany
dc.contributor.authoraffiliation[Haude, Michael] Lukaskrankenhaus Neuss, Neuss, Germany
dc.contributor.authoraffiliation[Jose Ruiz-Salmeron, Rafael] Hosp Virgen Macarena Sevilla, Seville, Spain
dc.contributor.authoraffiliation[Witkowski, Adam] Inst Cardiol, Warsaw, Poland
dc.contributor.authoraffiliation[Waksman, Ron] MedStar Washington Hosp Ctr, Washington, DC USA
dc.contributor.authoraffiliation[Saito, Shigeru] Shonan Kamakura Gen Hosp, Kamakura, Kanagawa, Japan
dc.date.accessioned2025-01-07T16:06:22Z
dc.date.available2025-01-07T16:06:22Z
dc.date.issued2019-10-01
dc.identifier.doi10.1016/j.jacc.2019.08.073
dc.identifier.essn1558-3597
dc.identifier.issn0735-1097
dc.identifier.urihttps://hdl.handle.net/10668/27624
dc.identifier.wosID487306300044
dc.issue.number13
dc.issue.numberB
dc.journal.titleJournal of the american college of cardiology
dc.journal.titleabbreviationJ. am. coll. cardiol.
dc.language.isoen
dc.organizationSAS - Hospital Universitario Virgen Macarena
dc.page.numberB43-B43
dc.publisherElsevier science inc
dc.titleA Prospective Randomized Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus-Eluting Stent in the Treatment of Subjects With Up to 2 De Novo Coronary Artery Lesions-BIOFLOW IV: 4-Year Clinical Results
dc.typeconference output
dc.volume.number74
dc.wostypeMeeting Abstract

Files